Literature DB >> 9361538

New renal scarring in children who at age 3 and 4 years had had normal scans with dimercaptosuccinic acid: follow up study.

S J Vernon1, M G Coulthard, H J Lambert, M J Keir, J N Matthews.   

Abstract

OBJECTIVE: To determine up to what age children remain at risk of developing a new renal scar from a urinary tract infection.
DESIGN: Follow up study. Families of children who had normal ultrasound scans and scanning with dimercaptosuccinic acid (DMSA) after referral with a urinary tract infection when aged 3 (209) or 4 (220) were invited to bring the children for repeat scans 2-11 years later. A history of infections since the original scan was obtained for children not having a repeat scan.
SETTING: Teaching hospital.
SUBJECTS: Children from three health districts in whom a normal scan had been obtained at age 3-4 years in 1985-1992 because of a urinary tract infection. MAIN OUTCOME MEASURE: Frequency of new renal scars in each age group.
RESULTS: In each group, about 97% of children either had repeat scanning (over 80%) or were confidently believed by their general practitioner or parent not to have had another urinary infection. The rate of further infections since the original scan was similar in the 3 and 4 year old groups (48/176 (27%)) and 55/179 (31%)). Few children in either group known to have had further urinary infections did not have repeat scanning (3/209 (1.4%) and 4/220 (1.8%)). In the 3 year old group, 2.4% (5/209) had one or more new kidney scars at repeat scanning (one sided 95% confidence interval up to 5.0%), whereas none of the 4 year olds did (one sided 95% confidence interval up to 1.4%). The children who developed scars were all aged under 3.4 years when scanned originally.
CONCLUSIONS: Children with a urinary tract infection but unscarred kidneys after the third birthday have about a 1 in 40 risk of developing a scar subsequently, but after the fourth birthday the risk is either very low or zero. Thus the need for urinary surveillance is much reduced in a large number of children.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9361538      PMCID: PMC2127615          DOI: 10.1136/bmj.315.7113.905

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  30 in total

1.  Prognosis for vesicoureteric reflux.

Authors:  K V Jones
Journal:  Arch Dis Child       Date:  1999-10       Impact factor: 3.791

2.  Cardiac causes for syncope or sudden death in childhood.

Authors:  C Wren
Journal:  Arch Dis Child       Date:  1999-10       Impact factor: 3.791

Review 3.  Imaging in childhood urinary tract infections: time to reduce investigations.

Authors:  Stephen D Marks; Isky Gordon; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2007-08-01       Impact factor: 3.714

Review 4.  Urinary tract infection in children: recurrent infections.

Authors:  James Larcombe
Journal:  BMJ Clin Evid       Date:  2015-06-12

Review 5.  Urinary tract infection in children.

Authors:  James Larcombe
Journal:  BMJ Clin Evid       Date:  2010-02-09

6.  The effect of vitamin E or vitamin A on the prevention of renal scarring in children with acute pyelonephritis.

Authors:  Behnam Sobouti; Nakysa Hooman; Mansour Movahed
Journal:  Pediatr Nephrol       Date:  2012-10-07       Impact factor: 3.714

Review 7.  Relevance of current guidelines in the management of VUR.

Authors:  Alexander Springer; Ramnath Subramaniam
Journal:  Eur J Pediatr       Date:  2014-01-03       Impact factor: 3.183

8.  Persistent renal cortical scintigram defects in children 2 years after urinary tract infection.

Authors:  Michael R Ditchfield; Keith Grimwood; David J Cook; Harley R Powell; Robert Sloane; Sanjeev Gulati; John F De Campo
Journal:  Pediatr Radiol       Date:  2004-04-22

9.  Vesicoureteric reflux is not a benign condition.

Authors:  Malcolm G Coulthard
Journal:  Pediatr Nephrol       Date:  2008-06-27       Impact factor: 3.714

10.  A nurse led education and direct access service for the management of urinary tract infections in children: prospective controlled trial.

Authors:  Malcolm G Coulthard; Sue J Vernon; Heather J Lambert; John N S Matthews
Journal:  BMJ       Date:  2003-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.